White Papers

  1. Bringing Novel ADC Formats Into The Clinic: AOC Process Development 9/3/2026

    Antibody-oligonucleotide conjugates introduce conjugation and purification challenges that standard ADC process development wasn't designed to solve. This white paper details practical approaches for each.

  2. AI Enabled Pharmaceutical Cocrystal Screening 9/3/2026

    Cocrystal candidate screening is resource-intensive and prone to gaps. This paper examines how AI-based modeling, trained on more than 20,000 data points, can sharpen candidate prioritization without sacrificing scientific rigor.

  3. Digital CMC Maturity: Rethinking QTTP And Control Strategy 9/2/2026

    Digital CMC maturity depends on structured, science- and risk-based knowledge. Learn how connecting development, validation, regulatory, and lifecycle information can accelerate timelines.

  4. Enhancing mAb Production: Advanced Downstream Purification Strategies 9/1/2026

    Explore how process optimization can address downstream mAb manufacturing bottlenecks, reduce labor and consumable costs, and support more efficient production without compromising performance.

  5. Optimizing mAb Production: Upstream Process Intensification Strategies 9/1/2026

    See how integrated upstream and downstream intensification strategies can increase monoclonal antibody yield, streamline workflows, improve facility utilization, and reduce manufacturing costs.

  6. Overview Of Hot Melt Extrusion And Its Pharmaceutical Applications 8/31/2026

    More than 40% of NCEs face aqueous solubility challenges. Here, we examine how hot melt extrusion addresses solubility, modified release, abuse deterrence, and scale-up across pharmaceutical development.

  7. Robust Database Characterizes And Optimizes Product Development 8/29/2026

    Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.

  8. Determining The True Cost Of Single-Use Fluid Management 8/24/2026

    Looking beyond unit price reveals how reliability, leak prevention, and shelf life affect bioprocessing costs. Make purchasing decisions that support resilient and predictable operations.

  9. SEDDS: Improving Oral Bioavailability Of Poorly Soluble Compounds 8/20/2026

    Nearly 90% of marketed drugs have poor water solubility. Learn how self-emulsifying drug delivery systems (SEDDS) resolve oral bioavailability failures across BCS Class II and IV compounds.

  10. Extraction And Chemical Characterization Pitfalls In Complex Medical Devices 8/20/2026

    Standard extraction protocols routinely fail tissue-derived products, hydrogels, absorbables, and silicone implants. Learn the material-specific study design strategies that prevent regulatory rejection and repeat work.